Hendra Lukman 
admin 
Nana O The Humble Pain Reliever: Could Ibuprofen Hold a Key to Cancer Prevention?
Lina carolina Ibuprofen, a ubiquitous over-the-counter medication trusted by millions for its efficacy in alleviating headaches, muscle...
Kobe University Researchers Develop Privacy-Preserving Artificial Intelligence for Early Detection of Acromegaly via Hand Imaging
Gabriel Paijo In a significant advancement for the field of endocrinology and medical diagnostics, a research team...
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Billy Candra Scientists at the Icahn School of Medicine at Mount Sinai have unveiled a groundbreaking experimental...
Ovarian Cancer Research Unveils How Hybrid Cell Clusters Drive Rapid Abdominal Spread and Chemotherapy Resistance
George Ongkojoyo The landscape of gynecological oncology is facing a potential paradigm shift following a groundbreaking study...
A Groundbreaking Discovery Targets Cancer’s Master Switch, Offering New Hope for Patients
Gilang Cahya Scientists at the Francis Crick Institute and Vividion Therapeutics have unveiled a revolutionary class of...
A Molecular Switch for Pancreatic Cancer Treatment Resistance Uncovered by Duke-NUS Researchers
Researchers at Duke-NUS Medical School have identified a crucial molecular "switch" that dictates whether pancreatic...
Stanford University Scientists Develop Universal Nasal Vaccine Capable of Neutralizing Broad Respiratory Viruses Bacteria and Allergens
In a landmark study that could redefine the future of preventive medicine, researchers at Stanford...
Deciphering T Cell Fate: New Genetic Mechanisms Unveiled to Reverse Exhaustion and Enhance Cancer Immunotherapy.
Budi Oetomo Narendra Researchers from the Salk Institute for Biological Studies, UNC Lineberger Comprehensive Cancer Center, and UC...
Dr. Vinay Prasad, Controversial Head of FDA’s Vaccines and Biologics Division, Confirmed to Depart Agency Amidst Scrutiny
Dr. Vinay Prasad, a figure known for his outspoken critical analyses within the medical community...
Vinay Prasad, Architect of Controversial Regulatory Shifts and Figure in FDA Leadership Turnover, Exits Agency for Second Time
WASHINGTON – Vinay Prasad, a prominent official at the Food and Drug Administration (FDA) whose...
